KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$9.77
-0.32 (-3.12%)
Open$10.11
Previous Close$10.09
Day High$10.48
Day Low$9.71
52W High$10.99
52W Low$3.65
Volume—
Avg Volume389.6K
Market Cap214.39M
P/E Ratio—
EPS$-14.84
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+403.0% upside
Current
$9.77
$9.77
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 296.77M | 304.06M | 24.30M |
| Net Income | -398,294,843 | -367,280,080 | -4,467,152 |
| Profit Margin | -134.2% | -127.5% | -18.4% |
| EBITDA | -310,396,578 | -302,127,816 | -5,147,496 |
| Free Cash Flow | — | — | -3,231,735 |
| Rev Growth | -2.4% | -2.4% | +18.6% |
| Debt/Equity | 3.78 | 3.78 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |